| Patient | Age years | Lung disease | Lung transplantation | Cultures prior to lung transplantation | Day of diagnosis | Microorganism | Antibiotics at diagnosis | Leukocytes ×109 cells·L−1 | Temperature °C | FIO2 | Chest radiograph | Purulent secretions | Time to death days | Gastroparesis | Most relevant abdominal symptoms/signs related with gastroparesis | |
| Donor | Recipient | |||||||||||||||
| 1 | 59 | COPD | Bilateral | 21 | E. cloacae ESBL | None | 4–15 | >38 | 0.6 | 2/4 | Yes | Yes | Abdominal distension and pain, CT scan with stomach dilation | |||
| 52 | P. aeruginosa | None | 4–15 | >38 | 1 | 2/4 | Yes | |||||||||
| 2 | 59 | COPD | Bilateral | S. maltophilia | 16 | Multi-resistant P. aeruginosa and E. cloacae | None | 4–15 | >38 | 0.3 | 1/4 | Yes# | Yes | Vomiting, stomach dilation on radiograph | ||
| 3 | 62 | COPD | Bilateral | S. aureus | 12 | Multi-resistant P. aeruginosa | None | >15 | >38 | 0.5 | 1/4 | Yes | Yes | Vomiting and abdominal pain, stomach dilation on radiograph | ||
| 4 | 50 | COPD | Bilateral | 28 | Multi-resistant P. aeruginosa | Meropenem | >15 | >38 | 0.7 | 3/4 | Yes | 33 | Yes | Abdominal distension, stomach dilation on radiograph | ||
| 5 | 55 | COPD | Bilateral | K. pneumoniae | 19 | A. fumigatus | Pipe-tazo Nebulised colistin | >15 | <38 | 0.5 | 1/4 | Yes | 162 | No | ||
| 6 | 49 | COPD | Bilateral | P. aeruginosa | 15 | Unknown¶ | Cefepime Nebulised colistin | >15 | <38 | 0.4 | 1/4 | Yes+ | Yes | Abdominal distension and pain, CT scan with stomach dilation | ||
| 7 | 64 | COPD | Bilateral | 44 | Multi-resistant P. aeruginosa | None | >15 | <38 | 0.4 | 1/4 | Yes# | 190 | Yes | Abdominal distension, CT scan with intestinal dilation | ||
| 8 | 57 | COPD | Bilateral | 65 | Unknown¶ | None | 4-15 | >38 | 0.4 | 1/4 | Yes+ | No | ||||
| 9 | 45 | COPD | Bilateral | 21 | MRSA | None | 4-15 | >38 | 0.6 | 2/4 | Yes | Yes | Abdominal distension, diarrhoea and stomach dilation on radiograph | |||
| 10 | 56 | COPD | Right | S. aureus | 16 | P. aeruginosa | Ceftazidime Amoxi-clav | 4–15 | >38 | 0.6 | 2/4§ | Yes | 81 | Yes | Abdominal distension, stomach dilation on radiograph | |
| 31 | S. maltophilia | Tigecycline Nebulised colistin | 4–15 | >38 | 1 | 3/4ƒ | Yes | |||||||||
| 70 | Multi-resistant P. aeruginosa | Meropenem Nebulised colistin | 4–15 | >38 | 0.6 | 3/4ƒ | Yes | |||||||||
| 11 | 18 | CF | Bilateral | Aspergillus spp. | S. maltophilia and MRSA | 15 | P. aeruginosa | Pipe-tazo | >15 | <38 | 0.5 | 1/4 | Yes | Yes | Vomiting and abdominal pain, stomach dilation on radiograph | |
| 12 | 62 | Histiocytosis X | Bilateral | M. tuberculosis | S. aureus and Haemophilus spp. | 13 | Unknown¶ | Anti-TB drugs | >15 | <38 | 0.8 | 1/4 | Yes | Yes | Nausea and vomiting, abdominal distension | |
| 13 | 57 | LAM | Bilateral | S. aureus | S. aureus | 0 | S. aureus | Amoxi-clav Aztreonam | >15 | >38 | 0.5 | 2/4 | Yes | 8 | No | |
| 14 | 46 | IPAH | Bilateral | S. aureus | 13 | Unknown¶ | Cefepime Nebulised colistin | >15 | <38 | 0.7 | 1/4 | Yes | Yes | Abdominal distension, diarrhoea, stomach dilation on radiograph | ||
| 15 | 46 | IPF | Bilateral | S. aureus | Multi-resistant P. aeruginosa | 55 | Multi-resistant P. aeruginosa | Nebulised colistin | >15 | <38 | 0.5 | 2/4 | Yes | 133 | Yes | Vomiting and abdominal pain |
| 106 | Multi-resistant P. aeruginosa | Amikacine Nebulised colistin | 4–15 | >38 | 0.5 | 1/4 | Yes | |||||||||
| 16 | 65 | IPF | Left | C. freundii | 33 | K. pneumoniae and E. cloacae | None | >15 | <38 | 0.7 | 2/4§ | Yes | Yes | Abdominal distension, diarrhoea | ||
| 17 | 65 | IPF | Left | Haemophilus spp. | 164 | Multi-resistant P. aeruginosa | Nebulised colistin | >15 | <38 | 0.5 | 2/4§ | Yes | 171 | Yes | Nausea and abdominal distension, diarrhoea, CT scan with stomach and colic dilation | |
| 18 | 49 | IPF | Right | S. aureus | S. aureus | 0 | S. aureus | None | <4 | <38 | 0.8 | 1/4## | Yes | 42 | Yes | Abdominal distension, CT scan with stomach and gallbladder dilation |
| 19 | 31 | CLAD | Right | 0 | E. aerogenes | None | >15 | >38 | 0.5 | 1/4§ | No+ | No | ||||
| 20 | 46 | IPF | Left | E. coli and S. pneumoniae | 5 | P. aeruginosa | Cefotaxime | >15 | <38 | 0.7 | 1/4§ | Yes | 26 | No | ||
Chest radiography data is presented as quadrants with opacities. FIO2: inspiratory oxygen fraction; COPD: chronic obstructive pulmonary disease; ESBL: extended-spectrum β-lactamase; CT: computed tomography; Pipe-tazo: piperacillin-tazobactam; Amoxi-clav: amoxicillin-clavulanate; CF: cystic fibrosis; TB: tuberculosis; LAM: lymphangioleiomyomatosis; IPAH: idiopathic pulmonary arterial hypertension; IPF: idiopathic pulmonary fibrosis; CLAD: chronic lung allograft dysfunction; E. cloacae: Enterobacter cloacae; P. aeruginosa: Pseudomonas aeruginosa; S. maltophilia: Stenotrophomonas maltophilia; S. aureus: Staphylococcus aureus; K. pneumoniae: Klebsiella pneumoniae; A. fumigatus: Aspergillus fumigatus; MRSA: methicillin-resistant S. aureus; M. tuberculosis: Mycobacterium tuberculosis; C. freundii: Citrobacter freundii; E. aerogenes: Enterobacter aerogenes; E. coli: Escherichia coli; S. pneumoniae: Streptococcus pneumoniae. #: dyspnoea; ¶: no histopathological evidence of acute rejection; +: rales; §: native quadrants; ƒ: native and graft quadrants; ##: graft quadrants.